According to the latest report by IMARC Group, titled, “Spine Biologics Market Size: Global Industry Trends, Share, Growth, Opportunity and Forecast 2022-2027″, The global spine biologics market size reached US$ 1.9 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 2.5 Billion by 2027, exhibiting a growth rate (CAGR) of 4.32% during 2022-2027.
Report Metric
Historical: 2016-2021
Base Year: 2020
Forecast Year: 2022-2027
Spine biologics refer to materials that are used during spine fusion surgery to treat spinal deformities. These tools are widely utilized by healthcare professionals as a preferred alternative to spinal orthoses. They promote bone growth while healing the injury, minimizing the disruption of soft tissues and reducing the requirement of additional surgical procedures. Spine biologics are also commonly utilized to treat deformities that occur due to degenerative disorders, traumas, and tumors.
Request a Free Sample Report: https://www.imarcgroup.com/spine-biologics-market/requestsample
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviors of the consumers globally and our estimates about the latest market trends and forecasts, are being done after considering the impact of this pandemic.
Spine Biologics Market Trends:
The global market is primarily driven by significant growth in the healthcare industry. Along with this, a considerable increase in investments from public and private firms across numerous countries to upgrade the existing healthcare infrastructure is providing an impetus to market growth. Moreover, continual technological advancements in the sector are also creating a positive outlook for the market. For instance, the widespread integration of robotics, artificial intelligence (AI), and third-dimensional (3D) printing with spine biologicsis expected to act as a major growth-inducing factor. Some of the other factors contributing to the market growth include the rising geriatric population and extensive research and development (R&D) activities.
Spine Biologics Market 2022-2027 Analysis and Segmentation:
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Arthrex Inc, Alphatec Holdings Inc., Exactech Inc, Johnson & Johnson, Medtronic plc, NuVasive Inc, Orthofix Medical Inc., Stryker Corporation, Wright Medical Group N.V. and Zimmer Biomet.
The report has segmented the market on the basis on a product, the surgery type, and end user.
Breakup by Product:
- Spinal Allografts
- Machined Bones Allograft
- Demineralized Bone Matrix
- Bone Graft Substitutes
- Bone Morphogenetic Proteins
- Synthetic Bone Grafts
- Cell Based Matrix
Breakup by Surgery Type:
- Open Spine Surgery
- Minimally Invasive Spine Surgery
Breakup by End User:
- Hospitals
- Ambulatory Care Centers
- Spinal Surgery Centers
- Orthopedic Clinics
- Others
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan,India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France,United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/request?type=report&id=4333&flag=C
If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Key highlights of the report:
Market Performance (2016-2021)
Market Outlook (2022- 2027)
Porter’s Five Forces Analysis
Market Drivers and Success Factors
SWOT Analysis
Value Chain
Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
